Blood flow and antithrombotic drug effects

Area of Science:

• Pharmacology
• Biomedical Engineering
• Hematology

Background:

• Antithrombotic drug efficacy is crucial for treating thrombotic disorders.
• Understanding blood flow dynamics in experimental thrombosis models is key to accurate drug testing.

Purpose of the Study:

• To review the role of blood flow phenomena in experimental thrombosis models for assessing antithrombotic drug efficacy.
• To analyze the characteristics and applications of perfusion chambers in thrombosis research.

Main Methods:

• Review of various perfusion chamber designs used in vitro, ex vivo, and in vivo.
• Analysis of studies involving human and animal blood under controlled flow conditions.
• Examination of shear-dependent effects of different antithrombotic agents.

Main Results:

• Shear-dependent antithrombotic effects were observed for anticoagulants (heparin, thrombin/factor Xa/VIIa inhibitors) and platelet inhibitors (aspirin, GP IIb/IIIa antagonists).
• The thrombogenic surface composition influences shear dependency; effects vary on tissue factor-rich vs. collagen-rich surfaces.
• Aspirin efficacy decreases at very high shear rates, while ADP pathway inhibitors and GP IIb/IIIa antagonists remain effective.

Conclusions:

• Shear-dependent models of experimental thrombosis are essential for evaluating antithrombotic pharmacologic agents.
• These models have shown predictive value for antithrombotic efficacy in humans.
• Perfusion chambers provide reproducible testing conditions for drug development.